Trxade Health Inc

NASDAQ:MEDS  
4.52
-0.07 (-1.52%)
Earnings Announcements

Trxade Group Reports Annual Revenue Growth Of 130% And Year End 2020 Financial Results

Published: 03/29/2021 21:17 GMT
Trxade Health Inc (MEDS) - Trxade Group Reports Annual Revenue Growth of 130% and Year End 2020 Financial Results.
Q4 Revenue Rose 17.1 Percent to $2.0 Million.
Q4 Loss per Share $0.29.
Cash, Cash Equivalents Were $5.9 Million As of Dec 31, 2020.
Revenue is expected to be $1.99 Million
Adjusted EPS is expected to be -$0.12

Next Quarter Revenue Guidance is expected to be $2.02 Million
Next Quarter EPS Guidance is expected to be -$0.12

More details on our Analysts Page.